Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8242235 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 8 Pages |
Abstract
Conclusions: A strategy of initial fixed-dose rate gemcitabine-based chemotherapy, followed by chemoradiation, shows promising efficacy for treatment of locally advanced disease. A substantial proportion of patients will be identified early on as having extrapancreatic disease and spared the potential toxicities associated with radiation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Andrew H. M.D., Jeanne M. M.D., Alan P. M.D., Emily K. M.D., Elizabeth R.N., Brian R.N., Margaret A. M.D.,